Jens H. Vogel
President & COO of Mirai Bio - Former CEO of BI Fremont & Global Head of Biotech at Bayer Pharmaceuticals

For the patients, we must do better.
Push boundaries, affect change
BILS 2025. The 17th Annual Bio Innovation Leaders Summit brings together c-suite, executives, pioneering thinkers and leading academics who are committed to breaking free from traditional silos to evolve and make an impact. Our curated programme is for leaders interested in strategy and innovation that will harness the full potential of the development of promising biologics and cell and gene therapies.
Agenda Framework
-
Empowering innovation in therapeutic proteins
-
The pursuit of excellence in innovative biologics
-
The convergence of Cell Science: Exploring synergies between biopharma and cultivated meat
-
Cutting edge and agile CDMO’s
-
Evolution of global supply chain pressuring COGS, impacting scalability and commercialisation
-
CarT 2.0 - innovative advanced potential of CarT therapies
-
To bring maximal benefit for patients we need to excel in technological development
-
Strategic donor sourcing to enhance quality and minimise variability of allogenic cells
CURRENT SPEAKERS

AGENDA SCHEDULE
Biologics
-
Risk sharing partnerships CDMO
-
Advance manufacturing
-
Single use innovation
-
Digital Twins
-
Process intensification
-
Process validation
-
Biologic workflow solutions
-
Bioprocessing Training
-
Quality control and analysis
-
Predict clinical outcomes
-
Impact global suppychain
-
Modular CDMO - site selection
-
Safety and Efficiency
-
Automation, digitising, robotics
-
Process optimisation
-
Leverage Regulatory Pathways
-
Cell engineering & development
-
Scaling and commercialisation
-
Customer acceptance
-
Survival - Valley of Death
-
Regulatory frameworks
-
Continuous processing
-
Technologies roles in culinary innovation
-
Investor roadmap
-
Cultivated meat tasting